Tag: Bimzelx
Hope for chronic arthritis patients
Pharma major UCB has announced the European Commission approval for Bimzelx (bimekizumab), its humanized monoclonal IgG1 antibody. Bimzelx is said to exert simultaneous selective...
This function has been disabled for HealthTekPak.